Kiromic BioPharma, Inc. (KRBP)

Last Closing Price: 2.78 (2023-06-02)

Company Description

Kiromic BioPharma Inc. is a discovery and gene-editing company utilizing artificial intelligence and a proprietary neural network platform with a therapeutic focus on immuno-oncology. Kiromic BioPharma Inc. is based in HOUSTON.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) --
Net Income (Most Recent Fiscal Year) $-34.73M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) --
Price to Book Ratio (Most Recent Quarterly Book Value per Share) --
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) --
Net Margin (Trailing 12 Months) --
Return on Equity (Trailing 12 Months) -475.16%
Return on Assets (Trailing 12 Months) -202.73%
Current Ratio (Most Recent Fiscal Quarter) 0.18
Quick Ratio (Most Recent Fiscal Quarter) 0.18
Debt to Common Equity (Most Recent Fiscal Quarter) 0.00
Inventory Turnover (Trailing 12 Months) --
Book Value per Share (Most Recent Fiscal Quarter) $-8.91
Earnings per Share (Most Recent Fiscal Quarter) --
Earnings per Share (Most Recent Fiscal Year) --
Diluted Earnings per Share (Trailing 12 Months) $-30.33
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Common Shares Outstanding 0.98M
Free Float 0.91M
Market Capitalization $2.72M
Average Volume (Last 20 Days) 0.32M
Beta (Past 60 Months) 0.18
Percentage Held By Insiders (Latest Annual Proxy Report) 7.33%
Percentage Held By Institutions (Latest 13F Reports) 12.62%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%